Michael Polark
Stock Analyst at Wolfe Research
(3.80)
# 1,948
Out of 4,595 analysts
177
Total ratings
50.6%
Success rate
6.1%
Average return
Main Sectors:
Stocks Rated by Michael Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Initiated Coverage: Hold | $135 | $138.37 | -2.44% | 1 | Jun 1, 2026 | |
| BRKR Bruker | Downgraded: Hold | n/a | $62.84 | - | 1 | Jun 1, 2026 | |
| DHR Danaher | Downgraded: Hold | n/a | $194.98 | - | 1 | Jun 1, 2026 | |
| MTD Mettler-Toledo International | Initiated Coverage: Hold | $1,180 | $1,416.30 | -16.68% | 1 | Jun 1, 2026 | |
| RVTY Revvity | Initiated Coverage: Hold | n/a | $112.52 | - | 1 | Jun 1, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $145 | $141.01 | +2.83% | 1 | Jun 1, 2026 | |
| TMO Thermo Fisher Scientific | Initiated Coverage: Buy | $535 | $574.30 | -6.84% | 1 | Jun 1, 2026 | |
| WAT Waters | Maintained: Buy | $425 | $377.31 | +12.64% | 1 | Jun 1, 2026 | |
| WST West Pharmaceutical Services | Rated: Buy | $375 | $340.96 | +9.98% | 1 | Jun 1, 2026 | |
| AVTR Avantor | Rated: Sell | $7 | $13.78 | -49.20% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $19.85 | +5.79% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.67 | - | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $46.73 | - | 6 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.40 | - | 5 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $105.70 | - | 5 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $92 | $86.07 | +6.89% | 8 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $50.21 | - | 15 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $39.28 | +19.65% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $85.39 | - | 6 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $13 | $12.89 | +0.85% | 11 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 → $270 | $228.40 | +18.21% | 17 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $17 | $17.86 | -4.82% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $12.83 | n/a | 1 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $60 | $80.14 | n/a | 19 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $350 | $165.35 | n/a | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $22.83 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $180 | $210.98 | n/a | 14 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $405 | $325.70 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $93.93 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $115 | $117.17 | n/a | 19 | Jun 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.64 | n/a | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 → $140 | $83.45 | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $136.71 | n/a | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $19.50 | n/a | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $315 | $353.33 | n/a | 9 | Apr 5, 2022 |
Agilent Technologies
Jun 1, 2026
Initiated Coverage: Hold
Price Target: $135
Current: $138.37
Upside: -2.44%
Bruker
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $62.84
Upside: -
Danaher
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $194.98
Upside: -
Mettler-Toledo International
Jun 1, 2026
Initiated Coverage: Hold
Price Target: $1,180
Current: $1,416.30
Upside: -16.68%
Revvity
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $112.52
Upside: -
Repligen
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $141.01
Upside: +2.83%
Thermo Fisher Scientific
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $535
Current: $574.30
Upside: -6.84%
Waters
Jun 1, 2026
Maintained: Buy
Price Target: $425
Current: $377.31
Upside: +12.64%
West Pharmaceutical Services
Jun 1, 2026
Rated: Buy
Price Target: $375
Current: $340.96
Upside: +9.98%
Avantor
Jun 1, 2026
Rated: Sell
Price Target: $7
Current: $13.78
Upside: -49.20%
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $19.85
Upside: +5.79%
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $15.67
Upside: -
May 29, 2026
Downgraded: Hold
Price Target: n/a
Current: $46.73
Upside: -
May 13, 2026
Maintained: Hold
Price Target: n/a
Current: $1.40
Upside: -
Apr 16, 2026
Maintained: Hold
Price Target: n/a
Current: $105.70
Upside: -
Apr 1, 2026
Upgraded: Buy
Price Target: $92
Current: $86.07
Upside: +6.89%
Feb 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $50.21
Upside: -
Jan 12, 2026
Initiated Coverage: Buy
Price Target: $47
Current: $39.28
Upside: +19.65%
Aug 25, 2025
Reiterated: Hold
Price Target: n/a
Current: $85.39
Upside: -
Aug 14, 2025
Maintained: Buy
Price Target: $14 → $13
Current: $12.89
Upside: +0.85%
Aug 8, 2025
Maintained: Buy
Price Target: $245 → $270
Current: $228.40
Upside: +18.21%
Aug 8, 2025
Maintained: Buy
Price Target: $19 → $17
Current: $17.86
Upside: -4.82%
May 29, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $12.83
Upside: n/a
May 19, 2025
Upgraded: Buy
Price Target: $60
Current: $80.14
Upside: n/a
May 12, 2025
Upgraded: Buy
Price Target: $350
Current: $165.35
Upside: n/a
Mar 31, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $22.83
Upside: n/a
Sep 17, 2024
Downgraded: Sell
Price Target: $180
Current: $210.98
Upside: n/a
Sep 9, 2024
Initiated Coverage: Buy
Price Target: $405
Current: $325.70
Upside: n/a
Sep 9, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $93.93
Upside: n/a
Jun 19, 2024
Upgraded: Buy
Price Target: $115
Current: $117.17
Upside: n/a
Oct 19, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $3.64
Upside: n/a
Jul 28, 2023
Maintained: Buy
Price Target: $121 → $140
Current: $83.45
Upside: n/a
Apr 25, 2023
Downgraded: Hold
Price Target: n/a
Current: $136.71
Upside: n/a
Jan 26, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $19.50
Upside: n/a
Apr 5, 2022
Initiated Coverage: Hold
Price Target: $315
Current: $353.33
Upside: n/a